Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
The European Respiratory Journal
|
May 3, 2005
Exhaled NO may predict the decline in lung function in bronchiolitis obliterans syndrome
O Brugière, G Thabut, H Mal, et al.
Bone Marrow Transplantation
|
January 10, 2017
Impact of Wilms' tumor 1 expression on outcome of patients undergoing allogeneic stem cell transplantation for AML
R Duléry, O Nibourel, J Gauthier, et al.
Leukemia
|
June 4, 2011
Mutation analysis of TET2, IDH1, IDH2 and ASXL1 in chronic myeloid leukemia
C Roche-Lestienne, A Marceau, E Labis, et al.
Leukemia Research
|
July 20, 2018
Outcomes and mutational analysis of patients with lower-risk non-del5q myelodysplastic syndrome treated with antithymocyte globulin with or without ciclosporine A
C Kelaidi, T Braun, R Arana, et al.
Leukemia
|
November 20, 2015
Molecular prognostic factors in acute myeloid leukemia receiving first-line therapy with azacitidine
J Desoutter, J Gay, C Berthon, et al.
Leukemia & Lymphoma
|
October 12, 2020
Effects of azacitidine in 93 patients with <i>IDH1/2</i> mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study
C Willekens, R Rahme, M Duchmann, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
The European Respiratory Journal
|
May 3, 2005
Exhaled NO may predict the decline in lung function in bronchiolitis obliterans syndrome
O Brugière, G Thabut, H Mal, et al.
Bone Marrow Transplantation
|
January 10, 2017
Impact of Wilms' tumor 1 expression on outcome of patients undergoing allogeneic stem cell transplantation for AML
R Duléry, O Nibourel, J Gauthier, et al.
Leukemia
|
June 4, 2011
Mutation analysis of TET2, IDH1, IDH2 and ASXL1 in chronic myeloid leukemia
C Roche-Lestienne, A Marceau, E Labis, et al.
Leukemia Research
|
July 20, 2018
Outcomes and mutational analysis of patients with lower-risk non-del5q myelodysplastic syndrome treated with antithymocyte globulin with or without ciclosporine A
C Kelaidi, T Braun, R Arana, et al.
Leukemia
|
November 20, 2015
Molecular prognostic factors in acute myeloid leukemia receiving first-line therapy with azacitidine
J Desoutter, J Gay, C Berthon, et al.
Leukemia & Lymphoma
|
October 12, 2020
Effects of azacitidine in 93 patients with <i>IDH1/2</i> mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study
C Willekens, R Rahme, M Duchmann, et al.
Page
of 2